Allogene (ALLO) 2025 Earnings: Milestones and Outlook
As allogene (allo) 2025 earnings loom, investors weigh pipeline progress, collaboration milestones, and cash runway. ...
Understanding when to start thinking about retirement can make a big difference. Explore key factors to help you plan effectively.
24,441 articlesAs allogene (allo) 2025 earnings loom, investors weigh pipeline progress, collaboration milestones, and cash runway. ...
Two memory stock stories illustrate a bigger question for investors: should you chase the momentum that Wall Street r...
A new ETF aims to monetize the price swings of Rocket Lab and other space names by selling weekly put spreads to fund...
Hims & Hers is weighing a bold strategy that could change how obesity treatment is sold. A new partnership and drug l...
In stock market today, march, Grab surprised investors with a substantial buyback and a bold Foodpanda expansion. Thi...
Investing hinges on leadership as much as numbers. This guide dives into how Josh D'Amaro's new approach could influe...
Cognex is navigating a world of AI-powered machine vision in manufacturing. This article breaks down the Q1 2026 resu...
A sudden 47% rise in Structure Therapeutics stock has traders buzzing while a major fund exits a multi-million dollar...
A big jump in ezcorp stock 130% has investors buzzing. This piece explains what happened, why an investor sold millio...
This in-depth look at Repositrak (TRAK) 2026 earnings breaks down the drivers behind revenue growth, margin trends, a...
Greg Abel, stepping into Warren Buffett's shadow, has quietly tripled Berkshire's Alphabet stake. Is this the kind of...
UiPath faced a cautious session as its Korea cloud launch tests regional demand. This article breaks down what happen...